GGrantIndex
Sort

1,049,261 grants matching t cell

NEW APPROACHES TO SURGICAL ONCOLOGY

$2,454,143
Donald L Morton · Saint John'S Cancer Institute · P01 · FY2008 · CA

RESEARCH-PGR: Enhancing grain yield under a changing climate.

$2,454,127
Ron Mittler · University Of Missouri-Columbia · · FY2024 · BIO

Arming the Immune System Against Pathogens

$2,453,989
Harvard University (Sch Of Public Hlth) · P01 · FY2003 · AI

SPORE in Soft Tissue Sarcoma

$2,453,831
Samuel Singer · Sloan-Kettering Inst Can Research · P50 · FY2025 · CA

Molecular Targeted Radionuclide Therapy for Tumor Immunomodulation and Enhancing Immunotherapy Response

$2,453,778
Jamey P Weichert · University Of Wisconsin-Madison · P01 · FY2022 · CA

Development of Novel Vaccine Strategies

$2,453,605
Jeffrey Schlom · Basic Sciences · Z01 · FY2007 · CA

ADVANCING VACCINE ADJUVANT RESEARCH FOR TUBERCULOSIS (AVAR-T)

$2,453,560
Warwick Britton · University Of Sydney · N01 · FY2022 · AI

Central Africa International Epidemiologic Database to Evaluate AIDS

$2,453,526
Kathryn M Anastos · Albert Einstein College Of Medicine · U01 · FY2020 · AI

Novel therapeutics for vesicants and toxic inhaled chemicals (U54)

$2,453,432
Carl W White · University Of Colorado Denver · U54 · FY2015 · ES

Biology of Mammalian Base Excision Repair and HIV-1 Replication

$2,453,425
Samuel H Wilson · National Institute Of Environmental Health Sciences · ZIA · FY2016 · ES

Triglycerides, Diabetes and Cardiovascular Disease

$2,453,240
Karin E. Bornfeldt · University Of Washington · P01 · FY2024 · HL

Transforming Human Pancreatic Cancer Into An Immunologic Disease

$2,453,222
Elizabeth Marion Jaffee · Johns Hopkins University · P01 · FY2024 · CA

A Protein Replacement Drug for Friedreichs Ataxia

$2,453,144
Elizabeth Ottinger · National Center For Advancing Translational Sciences · ZIA · FY2017 · TR

Repurposing an EU Therapeutic for Hemoglobinopathies

$2,453,144
Sharie Haugabook · National Center For Advancing Translational Sciences · ZIA · FY2017 · TR

INNOVATIVE VERSATILE AND COST-EFFECTIVE SOLID OXIDE FUEL CELL STACK CONCEPT

$2,452,924
University Of California, San Diego · · FY2017 · Department of Energy

Molecular Targeted Radionuclide Therapy for Tumor Immunomodulation and Enhancing Immunotherapy Response

$2,452,679
Jamey P Weichert · University Of Wisconsin-Madison · P01 · FY2023 · CA

Cellular Cardiomyoplasty for Acute and Chronic Ischemic

$2,452,541
Eduardo Marban · Cedars-Sinai Medical Center · U54 · FY2007 · HL

Interplay of B cells and HIV Leading to Broad Neutralizing Antibody Responses

$2,452,497
Pascal Poignard · International Aids Vaccine Initiative · U19 · FY2012 · AI

Convergent Epigenetic Control of Neuroendocrine Cancers

$2,452,400
James A Decaprio · Dana-Farber Cancer Inst · P01 · FY2025 · CA

Residual Beta Cell Function in Patients with Long-Term Type 1 Diabetes

$2,452,390
Rose A Gubitosi-Klug · Case Western Reserve University · DP3 · FY2014 · DK

Tissue compartmentalization of human lymphocytes

$2,452,058
Donna L Farber · Columbia University Health Sciences · P01 · FY2022 · AI

SAN DIEGO CHEMICAL LIBRARY SCREENING CENTER(RMI)

$2,452,025
Burnham Institute For Medical Research · U54 · FY2005 · HG

Cancer Center Support Grant - UT Southwestern Medical Center

$2,451,875
Carlos L Arteaga · Ut Southwestern Medical Center · P30 · FY2020 · CA

Structural Studies Of Post-Transcriptional Gene Regulation

$2,451,540
Traci M Hall · National Institute Of Environmental Health Sciences · ZIA · FY2014 · ES

Spore in Head and Neck Cancer

$2,451,382
David Sidransky · Johns Hopkins University · P50 · FY2015 · DE